Table 2 Demographic data collected at the end of the follow-up
Variables | Combined therapy group (n=27) | Aspirin group (n=26) | P | ||
|---|---|---|---|---|---|
Mean | Std | Mean | Std | ||
BMI (kg/m2) | 24.35 | 3.40 | 23.62 | 3.32 | 0.429 |
SBP (mmHg) | 142.00 | 13.65 | 152.36 | 22.00 | 0.044* |
DBP (mmHg) | 74.70 | 7.60 | 79.93 | 12.53 | 0.071 |
HbA1C (%) | 7.27 | 1.29 | 7.06 | 1.05 | 0.522 |
FBG (mmol/L) | 7.58 | 2.04 | 6.90 | 1.43 | 0.169 |
CHOL (mmol/L) | 4.55 | 1.14 | 4.93 | 1.03 | 0.209 |
TG (mmol/L) | 1.60 | 1.09 | 1.93 | 1.44 | 0.350 |
HDL-C (mmol/L) | 1.16 | 0.31 | 1.23 | 0.34 | 0.491 |
LDL-C (mmol/L) | 2.90 | 0.80 | 3.14 | 0.79 | 0.274 |
AST (U/L) | 17.26 | 4.64 | 23.65 | 11.62 | 0.011* |
ALT (U/L) | 18.04 | 7.71 | 22.69 | 16.78 | 0.198 |
BUN (mmol/L) | 6.67 | 2.23 | 6.60 | 2.62 | 0.921 |
CREA (μmol/L) | 101.85 | 28.56 | 99.84 | 30.87 | 0.807 |
CCR (ml/min) | 57.35 | 17.79 | 55.76 | 21.69 | 0.771 |
Medication use | |||||
Antihypertensive drugs (%) | 37.5 | / | 21.9 | / | 0.171 |
Insulin (%) | 21.9 | / | 9.4 | / | 0.302 |
Statins (%) | 9.4 | / | 3.1 | / | 0.613 |